Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • ICMR and Sun Pharma...

    ICMR and Sun Pharma join hands to fight Malaria

    Written by savita thakur thakur Published On 2016-04-26T11:27:59+05:30  |  Updated On 26 April 2016 11:27 AM IST
    ICMR and Sun Pharma join hands to fight Malaria

    New Delhi : Drug major Sun Pharmaceutical Industries entered into a partnership with the Indian Council of Medical Research (ICMR) and Madhya Pradesh government for a malaria eradication programme and other innovation in preventive health measures. Under the public-private-partnership stakeholders will jointly undertake malaria control and elimination programme by setting-up management and technical committees to provide oversight for disease surveillance and elimination.


    "Through our Malaria Free India initiative we aim to achieve zero malaria incidences in more than 1,200 villages of Mandla district of Madhya Pradesh by FY21," Sun Pharma Managing Director Dilip Shanghvi said here at the launch of the partnership.


    The experience gained from Mandla project will guide the development of broader plans for malaria elimination in Madhya Pradesh as well as other high malaria endemic states in India, he added.


    Stressing on the need for taking up such an initiative, Shanghvi said: "Malaria is a major public health problem. It is known to impede development, saving and investment as well as worker productivity in the form of absenteeism. All this has an adverse impact on per-capita gross domestic product."


    ICMR Director General Indian Council Soumya Swaminathan said malaria is not uniformly distributed in India and six locations Odisha, Chhattisgarh, Madhya Pradesh, Jharkhand, Maharashtra and Northeastern states are responsible for over 60 per cent malaria in the country.


    "This project aims to demonstrate that it is feasible to eliminate malaria from a high endemic district, and will hopefully become a pathfinder for the rest of the country," Swaminathan said.


    It is also a unique model of collaboration between the central and state governments, a private pharma company and ICMR, and could pave the way for more private investment in public health, she added.


    "The proposed public-private partnership for malaria elimination will use the same available and tested strategies of case management, intense surveillance and vector control by using indoor residual sprays and long-lasting insecticide impregnated bednets," Swaminathan added.


    Madhya Pradesh Health & Family Welfare Minister Narottam Mishra said: "I hope that this collaboration, which is starting from district Mandla, will expand to other districts and enable us to achieve the ambitious goals we have set for ourselves."


    To achieve the 'Malaria Free India' goals, Sun Pharma will establish a not-for-profit foundation, the company said, adding the Foundation would operate as an independent entity by engaging national and international experts as knowledge partners for the project while remaining accountable to the Malaria Free India public-private- partnership stakeholders.


    A team of over 200 members will be part of the implementation of this demonstration project, it added. AKT PLB RKL MR

    Dilip ShanghviICMRIndian Council of Medical ResearchMadhya Pradesh Health & Family WelfareMalaria EradicationMalaria Free IndiaNarottam MishraSun Pharma
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok